---LUNCH 12:30 p.m. – 1:00 p.m. --- Suite 300*
b.
Q Fever (1:00 p.m. – 2:00 p.m.)
- James Samuel, College of Medicine, Texas A&M
i.
Overview & Challenges
ii.
Fitness for Purpose Statement
c.
Staphylococcus Enterotoxin B (SEB) (2:00 p.m. – 3:00 p.m.) –
Sandra Tallent, FDA, CFSAN
i.
Overview & Challenges
ii.
Fitness for Purpose Statement
---Break 3:00 p.m. –3:15 p.m.. ---
VIII.
SPADA’s Future Priorities (3:15 p.m. – 4:30 p.m.)
All stakeholders are invited to participate in a discussion of SPADA’s future priorities and future
support structure.
“Test and Evaluation Capability and Methodology Integrated Process Team
(TECMIPT)
Reset, Sustain, Prepare, and Modernize”
*Lunch provided by AOAC on both days. No federal funds were used for the lunch.
V7.2
